PDL Biopharma
PDLI
#8017
Rank
NZ$0.48 B
Marketcap
NZ$4.23
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -NZ$0.21 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are NZ$80.61 Million. In 2019 the company made an earning of -NZ$0.11 Billion a decrease over its 2018 earnings that were of -NZ$74.97 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-NZ$0.21 Billion93.94%
2019-NZ$0.11 Billion42.43%
2018-NZ$74.97 Million-121.38%
2017NZ$0.35 B60.41%
2016NZ$0.21 B-77.09%
2015NZ$0.95 B3.09%
2014NZ$0.92 B26.65%
2013NZ$0.73 B19.82%
2012NZ$0.61 B3.68%
2011NZ$0.58 B77.17%
2010NZ$0.33 B-35.29%
2009NZ$0.51 B23.45%
2008NZ$0.41 B-1751.42%
2007-NZ$25.18 Million-88.56%
2006-NZ$0.23 Billion93.73%
2005-NZ$0.12 Billion13.63%
2004-NZ$99.94 Million32.12%
2003-NZ$75.64 Million87.44%
2002-NZ$40.36 Million-302.45%
2001NZ$19.93 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$38.54 B-17,205.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.12 B-6,366.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$47.21 Million-79.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-NZ$0.2 Billion-13.51%๐Ÿ‡บ๐Ÿ‡ธ USA